€300 million savings for Unilever
All 26 of Unilever’s manufacturing and non-manufacturing headquarter facilities in the US and Canada are now zero waste to landfill (ZLF) and other countries in which it has achieved this milestone include the United Kingdom, the Netherlands, France, Germany and Japan. |
Lenzing Plastics changeover
In a move to further concentrate on its core cellulose fibres business for nonwovens and textiles, Lenzing AG is to sell 85% of Lenzing Plastics to an Austrian bidding consortium led by Invest AG, based in Linz. |
Lutradur ECO with Repreve
Among new products to showcased at next week’s IDEA nonwovens show in Miami by Freudenberg is Lutradur ECO made with Unifi's Repreve. |
Hollow advantage with Bramante
While the need for discrete incontinence solutions is growing, the waste problem with these products is also increasing. |
Bostik inaugurates new China plant
Total company Bostik last week inaugurated its new state-of-the-art manufacturing plant in Changshu, China for the production of hot melt adhesives, polyester, polyurethane and sealants dedicated to the industrial markets for nonwovens and disposable hygiene, packaging, transportation and textiles. |
Colour connection at IDEA
A custom-built spunbonded pilot line at its plant in Dalton, Georgia, enables Americhem to assist customers in achieving faster speed to market when developing new products. |
Lenzing leads with new report
What is without doubt one of the most substantial sustainability reports to date in terms of both transparancy and detail has just been published by Austria’s Lenzing Group, the leading supplier of cellulose fibres for nonwovens and textiles. |
Smart AI product launch imminent
The Taiwan Industrial Technology Research Institute and nonwovens manufacturer KNH Enterprise are planning to jointly launch ‘smart’ hygienic disposables by the end of this year. |
Platform for biodegradable implantables
TissueGen is partnering with Biomedical Structures (BMS) to develop a finished textile platform for medical device applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopaedics and sutures, using TissueGen’s patented drug delivery technology. |
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
Copyright MCL Global 2013. You may share using our article tools. Please don’t cut articles from ecotextile.com and redistribute by email or post to the web.
